GB9614191D0 - Oxadiazole benzenesulfonamides as selectives B3 agonists for the treatment of diabetes and obesity - Google Patents

Oxadiazole benzenesulfonamides as selectives B3 agonists for the treatment of diabetes and obesity

Info

Publication number
GB9614191D0
GB9614191D0 GBGB9614191.6A GB9614191A GB9614191D0 GB 9614191 D0 GB9614191 D0 GB 9614191D0 GB 9614191 A GB9614191 A GB 9614191A GB 9614191 D0 GB9614191 D0 GB 9614191D0
Authority
GB
United Kingdom
Prior art keywords
selectives
obesity
agonists
diabetes
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9614191.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GBGB9614191.6A priority Critical patent/GB9614191D0/en
Publication of GB9614191D0 publication Critical patent/GB9614191D0/en
Priority to CA002257206A priority patent/CA2257206A1/en
Priority to AU33748/97A priority patent/AU712057B2/en
Priority to JP10500782A priority patent/JP2000511903A/en
Priority to EP97929769A priority patent/EP0906310A4/en
Priority to PCT/US1997/009536 priority patent/WO1997046556A1/en
Pending legal-status Critical Current

Links

GBGB9614191.6A 1996-06-07 1996-07-05 Oxadiazole benzenesulfonamides as selectives B3 agonists for the treatment of diabetes and obesity Pending GB9614191D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9614191.6A GB9614191D0 (en) 1996-07-05 1996-07-05 Oxadiazole benzenesulfonamides as selectives B3 agonists for the treatment of diabetes and obesity
CA002257206A CA2257206A1 (en) 1996-06-07 1997-06-03 Oxadiazole benzenesulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
AU33748/97A AU712057B2 (en) 1996-06-07 1997-06-03 Oxadiazole benzenesulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
JP10500782A JP2000511903A (en) 1996-06-07 1997-06-03 Oxadiazole benzenesulfonamide as a selective beta 3 agonist for the treatment of diabetes and obesity
EP97929769A EP0906310A4 (en) 1996-06-07 1997-06-03 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE -g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
PCT/US1997/009536 WO1997046556A1 (en) 1996-06-07 1997-06-03 OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9614191.6A GB9614191D0 (en) 1996-07-05 1996-07-05 Oxadiazole benzenesulfonamides as selectives B3 agonists for the treatment of diabetes and obesity

Publications (1)

Publication Number Publication Date
GB9614191D0 true GB9614191D0 (en) 1996-09-04

Family

ID=10796450

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9614191.6A Pending GB9614191D0 (en) 1996-06-07 1996-07-05 Oxadiazole benzenesulfonamides as selectives B3 agonists for the treatment of diabetes and obesity

Country Status (1)

Country Link
GB (1) GB9614191D0 (en)

Similar Documents

Publication Publication Date Title
EP0906310A4 (en) OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE -g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
HUP0002053A3 (en) Thiazole benzenesulfonamides as beta3 agonists for the treatment of diabetes and obesity
GB9619331D0 (en) Selective ›3 agonists for the treatment of diabetes and obesity
EP0915847A4 (en) Substituted sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
HU9602951D0 (en) Substituted sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
ZA953336B (en) Substituted sulfonamides as selective B3 agonists for the treatment of diabetes and obesity
HK1005648A1 (en) Device for suturing blood vessels and the like
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
EP2295453A3 (en) An appetite-suppressing peptide, its compositions and use
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
AU4714393A (en) Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity
GB9618934D0 (en) Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity
ZA98647B (en) Thiazole benzenesulfonamides as beta3 agonists for the treatment of diabetes and obesity
IL133136A0 (en) Use of leptin antagonists for the treatment of diabetes
HUP9904075A3 (en) Composition, for the treatment of asthma,containing loratadine and a decongestant
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
EP0858340A4 (en) Combination therapy for the treatment of diabetes and obesity
EP0969852A4 (en) Combination therapy for the treatment of diabetes and obesity
GB9606076D0 (en) Diabetes treatment
PL337577A1 (en) Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor
GB9614191D0 (en) Oxadiazole benzenesulfonamides as selectives B3 agonists for the treatment of diabetes and obesity
ZA961346B (en) Process for the preparation of oxazolidinones novel oxazolidinones and the use of oxazolidinones
GB9604102D0 (en) Selective ›3 agonists for the treatment of diabetes and obesity
GB9605164D0 (en) Selective ›3 agonists for the treatment of diabetes and obesity
GB9705041D0 (en) Thiazole benzenesulfonamides as selective B3 agonists for the treatment of diabetes and obesity